Comparative Bioavailability Study of an Immediate Release and Controlled Release Oral Formulations of Huperzine A

Unknown 8 enrolled Hadassah Medical Organization Hebrew University of Jerusalem · collab

RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to develop oral controlled release formulation of Huperzine A that will provide optimal pharmacokinetic profile of the drug enhancing safety and compliance, as possible cure to neurodegenerative disorders.

Timeline

Start: 2010-09
Primary completion: 2011-01
Completion: 2011-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Huperzine A	Traditional medicine (herbal / TCM)	0.4 mg	Oral

Indications

No indication recorded.